News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Mark Geyer: Tigen Pharma has formally agreed to partner with us in clinical development of our CAR T-cell product for AML
Photo of Mark Geyer taken from www.mskcc.org
Feb 2, 2024, 05:57

Mark Geyer: Tigen Pharma has formally agreed to partner with us in clinical development of our CAR T-cell product for AML

Mark Geyer, Assistant Attending Physician at Memorial Sloan Kettering Cancer Center, recently shared on X/Twitter:

“Thrilled that Tigen Pharma has formally agreed to partner with us in clinical development of our CD371-targeted IL-18 secreting CAR T-cell product for AML, currently in a phase I study I’m leading at Memorial Sloan Kettering Cancer Center with plans to expand.”

Read further.

Source: Mark Geyer/X

AML cancer CAR T-CELL IL-18 Mark Geyer OncoDaily Oncology Research Tigen Pharma
Special Coverage
Blog
Mar 26, 2025, 14:11
ECOG-ACRIN Cancer Research Group is now enrolling for EAQ222CD/CostCOM
Science
Mar 26, 2025, 14:03
Nita Radhakrishnan: Cost analysis of thalassemia screening vs treatment in different health care sectors
Blog
Mar 26, 2025, 14:01
Steve Bierman on his two decades on the front lines of emergency medicine - SPCC
Celebrities
Mar 26, 2025, 14:00
Miranda McKeon: Battling Breast Cancer at 19, Inspiring Millions on Instagram
Blog
Mar 26, 2025, 13:52
Tilly Metz: We must ensure the next EU4Health program remains comprehensive, ambitious, and continues to support public health efforts and NGOs
Blog
Mar 26, 2025, 13:44
Laura Bukavina: This is the kind of innovation we need in Bladder Cancer
Blog
Mar 26, 2025, 13:44
Ronak H. Mistry: Excited to share two MedEd abstracts at ASCO 2025
Insight
Mar 26, 2025, 13:43
Swati G. Patel: Optimizing Bowel Preparation Quality for Colonoscopy
Blog
Mar 26, 2025, 13:43
UICC urges governments to commit to a 50% reduction in health impacts at the UN High-Level Meeting
Blog
Mar 26, 2025, 13:38
Antonio Calles: Final overall survival of MARIPOSA trial
Blog
Mar 26, 2025, 13:32
Noemi Reguart: MARIPOSA (Ami + Lazer) show OS superiority over SoC in first line EGFRm NSCLC
Blog
Mar 26, 2025, 13:31
The urgent need for transformative solutions in colorectal cancer treatment - Agenus